Background: The American Heart Association, in conjunction with the National Institutes of
Health, annually reports the most up-to-date statistics related to heart disease, stroke, and …

Background: The American Heart Association, in conjunction with the National Institutes of
Health, annually reports the most up-to-date statistics related to heart disease, stroke, and …

The main inherited cardiac arrhythmias are long QT syndrome, short QT syndrome,
catecholaminergic polymorphic ventricular tachycardia and Brugada syndrome. These rare …

Catecholaminergic polymorphic ventricular tachycardia (CPVT) is an inherited
arrhythmogenic disease occurring in patients with a structurally normal heart: the disease is …

Background—The pathophysiological background of catecholaminergic polymorphic
ventricular tachycardia is well understood, but the clinical features of this stress-induced …

Optimal cardiac function depends on proper timing of excitation and contraction in various
regions of the heart, as well as on appropriate heart rate. This is accomplished via …

Objectives: This study evaluated the efficacy and safety of flecainide in addition to
conventional drug therapy in patients with catecholaminergic polymorphic ventricular …

Channelopathies are a heterogeneous group of disorders resulting from the dysfunction of
ion channels located in the membranes of all cells and many cellular organelles. These …

Although sinus node dysfunction (SND) and atrial arrhythmias frequently coexist and
interact, the putative mechanism linking the 2 remain unclear. Although SND is …

Background—Catecholaminergic polymorphic ventricular tachycardia is an uncommon,
potentially lethal, ion channelopathy. Standard therapies have high failure rates and little is …